
|Articles|March 31, 2022
OM1 Launches New Mental Health and Neuroscience Real-World Data Network
Specialty area to focus on major depression, schizophrenia, multiple sclerosis, and more.
Advertisement
OM1 announced the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric disorders and diseases of the central nervous system (CNS) with an initial focus on major depression, schizophrenia, bipolar disorder, and multiple sclerosis (MS) with other condition areas to follow.
Read more about the new network
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape
2
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
3
Centering Site Experience to Accelerate Study Activation
4
ACT Brief: Global Trials Scale Up, Site-Centric Startup Gains Focus, and Pfizer Expands Vaccine Partnerships
5



